Spots Global Cancer Trial Database for A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
Official Title: A Prospective Clinical Trial of Tumor Immunomodulation Using Tumor-Treating Fields (TTFields) in Patients With Early-Stage Resectable Lung Adenocarcinoma
Study ID: NCT05764954
Conditions
Interventions
Study Description
Brief Summary: The researchers are doing this study to find out if treatment with TTFields using the NovoTTF-200T System is safe and practical (feasible) before surgical removal (resection) of lung adenocarcinoma (ADC). The researchers will also look at how the treatment may help the body's immune system to fight cancer.
Detailed Description:
Eligibility
Minimum Age: 22 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Consent Only), Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Consent Only), Montvale, New Jersey, United States
Memorial Sloan Kettering Suffolk - Commack (Consent Only), Commack, New York, United States
Memorial Sloan Kettering Westchester (Consent Only), Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
Memorial Sloan Kettering Nassau (Consent Only), Uniondale, New York, United States
Contact Details
Name: Prasad Adusumilli, MD
Affiliation: Memorial Sloan Kettering Cancer Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
